Moderna announced new data on Wednesday suggesting a new version of its COVID-19 vaccine will offer superior protection to its original formulation of shots, based on studying antibodies generated by ...

Moderna hopes to offer updated COVID-19 boosters in the fall that combine the original vaccine with protection against the latest variant. Now it's reporting a hint that such an approach might work.

Labor Department Officials Frustrated With White House Over COVID-19 Vaccine and Testing Mandate The FDA Authorized a Booster ...

The Food and Drug Administration's vaccine advisory panel on Thursday unanimously endorsed use of Moderna's Covid-19 booster shot for the elderly and younger people whose jobs, underlying health or ...

Moderna’s CEO, Stéphane Bancel, said he anticipates the world will see many covornavirus variants in the months ahead as it races to vaccinate the population against COVID-19 and stem the pandemic.

Moderna stock reflects a transition phase for the mRNA specialist as COVID vaccine sales normalize and the company leans on oncology, flu and other late-stage candidates to support future growth.

Moderna defied expectations of a Covid-revenue slowdown on Friday as a surge in international vaccine sales underpinned its first-quarter results. Investors remain wary. Revenue more than tripled in ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Moderna’s bivalent COVID-19 booster vaccine for adults. The vaccine’s composition is split evenly between components ...

Moderna Inc said on Thursday it is developing a single vaccine that combines a booster dose against COVID-19 with its experimental flu shot. The company hopes to eventually add vaccines it is working ...